Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04760574

Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism

Cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population

Recruiting

Interested in participating?

Request Info

Key information

Age range

20 year and older

Sex eligibility

Male

Study type

Observational

Primary location

National Taiwan University Hospital

Taipei, 100, Taiwan

Location status: Recruiting

Location contact

Shyang-Rong Shih, Ph.D.

CONTACT

[email protected]

+886-2-2312-3456 ext. 61613

About this study

In this study, we conduct a cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population. Age-matched non-HIV infected MSM group will be used as comparison group. We will also determine the risk factors associated with male hypogonadism (age, duration of HIV infection, comorbidities, BMI, ART use). Correlation will be made between serum testosterone levels and sexual function, vitality, exercise capacity, mood, and bone mineral density.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • HIV-infected men who have sex with men
  • HIV non-infected men

Exclusion criteria

  • Use of testosterone supplement, anabolic steroid in the past one year.
  • History of pituitary , adrenal or gonad diseases
  • History of pituitary surgery or radiation therapy
  • History of systemic chemotherapy
  • Active opportunistic infection under treatment
  • Cancer
  • Severe hepatic, renal or cardiac impairment

Treatment and study plan

Testosterone

Diagnostic Test

Serum total testosterone and free testosterone level

Primary outcomes

  1. Symptoms of androgen deficiency

    Time frame: 2021-2030

    We use the score of Androgen Deficiency in Aging Males (ADAM) questionnaire to study the prevalence of hypogonadism in HIV-infected MSM population

  2. Serum free testosterone

    Time frame: 2021-2030

    We use serum free testosterone to study the prevalence of hypogonadism in HIV-infected MSM population

Study contacts

Contact information is provided by the study sponsor or research team.

Shyang-Rong Shih, Ph.D.

CONTACT

[email protected]

+886-2-2312-3456 ext. 61613

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Important dates

Study start
2021
Primary completion
2030
Study completion
2030
First posted
Feb 18, 2021
Registry last updated
Mar 3, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.